{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:08:46Z","timestamp":1791464926937,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["132140-PF-18-127-01-CSM"],"award-info":[{"award-number":["132140-PF-18-127-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["2U01EB012493"],"award-info":[{"award-number":["2U01EB012493"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA214297"],"award-info":[{"award-number":["U01CA214297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["2R01CA129933"],"award-info":[{"award-number":["2R01CA129933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["2U01EB012493"],"award-info":[{"award-number":["2U01EB012493"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA214297"],"award-info":[{"award-number":["U01CA214297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA214297"],"award-info":[{"award-number":["U01CA214297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001767","name":"National Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001767","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Blood-borne metastasis to the brain is a major complication of breast cancer, but cellular pathways that enable cancer cells to selectively grow in the brain microenvironment are poorly understood. We find that cultured circulating tumor cells (CTCs), derived from blood samples of women with advanced breast cancer and directly inoculated into the mouse frontal lobe, exhibit striking differences in proliferative potential in the brain. Derivative cell lines generated by serial intracranial injections acquire selectively increased proliferative competency in the brain, with reduced orthotopic tumor growth. Increased Hypoxia Inducible Factor 1A (HIF1A)-associated signaling correlates with enhanced proliferation in the brain, and shRNA-mediated suppression of HIF1A or drug inhibition of HIF-associated glycolytic pathways selectively impairs brain tumor growth while minimally impacting mammary tumor growth. In clinical specimens, brain metastases have elevated HIF1A protein expression, compared with matched primary breast tumors, and in patients with brain metastases, hypoxic signaling within CTCs predicts decreased overall survival. The selective activation of hypoxic signaling by metastatic breast cancer in the brain may have therapeutic implications.<\/jats:p>","DOI":"10.1038\/s41467-020-20144-w","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T06:39:11Z","timestamp":1607495951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["HIF1A signaling selectively supports proliferation of breast cancer in the brain"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-5810","authenticated-orcid":false,"given":"Richard Y.","family":"Ebright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus A.","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-9914","authenticated-orcid":false,"given":"Douglas S.","family":"Micalizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5657-9849","authenticated-orcid":false,"given":"Ben S.","family":"Wittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira L.","family":"Niederhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda T.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Chirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon F.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Nieblas-Bedolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Atlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-9914","authenticated-orcid":false,"given":"Annamaria","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Toner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-2322","authenticated-orcid":false,"given":"David T.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-8425","authenticated-orcid":false,"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-6551","authenticated-orcid":false,"given":"Daniel A.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-1709","authenticated-orcid":false,"given":"Shyamala","family":"Maheswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"20144_CR1","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret, E. et al. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 32, 4655\u20134662 (2012).","journal-title":"Anticancer Res."},{"key":"20144_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos, P. K. et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Disco. 5, 1164\u20131177 (2015).","journal-title":"Cancer Disco."},{"key":"20144_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging biological principles of metastasis. Cell 168, 670\u2013691 (2017).","journal-title":"Cell"},{"key":"20144_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005\u20131009 (2009).","journal-title":"Nature"},{"key":"20144_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","volume":"156","author":"M Valiente","year":"2014","unstructured":"Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002\u20131016 (2014).","journal-title":"Cell"},{"key":"20144_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/2159-8290.CD-19-0384","volume":"10","author":"R Klotz","year":"2020","unstructured":"Klotz, R. et al. Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers. Cancer Disco. 10, 86\u2013103 (2020).","journal-title":"Cancer Disco."},{"key":"20144_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"133","author":"S Paget","year":"1889","unstructured":"Paget, S. The distribution of secondary growths of cancers of the breast. Lancet 133, 571\u2013573 (1889).","journal-title":"Lancet"},{"key":"20144_CR8","first-page":"2281","volume":"40","author":"IR Hart","year":"1980","unstructured":"Hart, I. R. & Fidler, I. J. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40, 2281\u20132287 (1980).","journal-title":"Cancer Res"},{"key":"20144_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","volume":"153","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi, K. J. et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865\u2013873 (1998).","journal-title":"Am. J. Pathol."},{"key":"20144_CR10","first-page":"2541","volume":"60","author":"MD Cameron","year":"2000","unstructured":"Cameron, M. D. et al. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 60, 2541\u20132546 (2000).","journal-title":"Cancer Res."},{"key":"20144_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","volume":"15","author":"A Carreau","year":"2011","unstructured":"Carreau, A., El Hafny-Rahbi, B., Matejuk, A., Grillon, C. & Kieda, C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J. Cell Mol. Med. 15, 1239\u20131253 (2011).","journal-title":"J. Cell Mol. Med."},{"key":"20144_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/glycob\/6.5.489","volume":"6","author":"E Ruoslahti","year":"1996","unstructured":"Ruoslahti, E. Brain extracellular matrix. Glycobiology 6, 489\u2013492 (1996).","journal-title":"Glycobiology"},{"key":"20144_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294\u2013309 (2010).","journal-title":"Mol. Cell"},{"key":"20144_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1947601911423654","volume":"2","author":"BL Krock","year":"2011","unstructured":"Krock, B. L., Skuli, N. & Simon, M. C. Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2, 1117\u20131133 (2011).","journal-title":"Genes Cancer"},{"key":"20144_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409238.2013.838205","volume":"49","author":"VL Dengler","year":"2014","unstructured":"Dengler, V. L., Galbraith, M. & Espinosa, J. M. Transcriptional regulation by hypoxia inducible factors. Crit. Rev. Biochem. Mol. Biol. 49, 1\u201315 (2014).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"20144_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin, E. B. & Giaccia, A. J. Hypoxic control of metastasis. Science 352, 175\u2013180 (2016).","journal-title":"Science"},{"key":"20144_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1631\/jzus.B1400221","volume":"16","author":"ZJ Liu","year":"2015","unstructured":"Liu, Z. J., Semenza, G. L. & Zhang, H. F. Hypoxia-inducible factor 1 and breast cancer metastasis. J. Zhejiang Univ. Sci. B 16, 32\u201343 (2015).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"20144_CR18","first-page":"3175","volume":"56","author":"D Saha","year":"2011","unstructured":"Saha, D. et al. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.J. Vis. Exp. 56, 3175 (2011).","journal-title":"J. Vis. Exp."},{"key":"20144_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/B:CLIN.0000024761.00373.55","volume":"21","author":"LS Kim","year":"2004","unstructured":"Kim, L. S., Huang, S., Lu, W., Lev, D. C. & Price, J. E. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin. Exp. Metastasis 21, 107\u2013118 (2004).","journal-title":"Clin. Exp. Metastasis"},{"key":"20144_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2017.00193","volume":"8","author":"KA Bohn","year":"2017","unstructured":"Bohn, K. A., Adkins, C. E., Nounou, M. I. & Lockman, P. R. Inhibition of VEGF and angiopoietin-2 to reduce brain metastases of breast cancer burden. Front Pharm. 8, 193 (2017).","journal-title":"Front Pharm."},{"key":"20144_CR21","doi-asserted-by":"publisher","first-page":"C775","DOI":"10.1152\/ajpcell.00279.2015","volume":"309","author":"ME Hubbi","year":"2015","unstructured":"Hubbi, M. E. & Semenza, G. L. Regulation of cell proliferation by hypoxia-inducible factors. Am. J. Physiol. Cell Physiol. 309, C775\u2013C782 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"20144_CR22","doi-asserted-by":"publisher","first-page":"179ra147","DOI":"10.1126\/scitranslmed.3005616","volume":"5","author":"E Ozkumur","year":"2013","unstructured":"Ozkumur, E. et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5, 179ra147 (2013).","journal-title":"Sci. Transl. Med."},{"key":"20144_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","volume":"345","author":"M Yu","year":"2014","unstructured":"Yu, M. et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345, 216\u2013220 (2014).","journal-title":"Science"},{"key":"20144_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature19328","volume":"537","author":"NV Jordan","year":"2016","unstructured":"Jordan, N. V. et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature 537, 102\u2013106 (2016).","journal-title":"Nature"},{"key":"20144_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1126\/science.aay0939","volume":"367","author":"RY Ebright","year":"2020","unstructured":"Ebright, R.Y. et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.Science 367, 1468\u20131473 (2020).","journal-title":"Science"},{"key":"20144_CR26","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.4103\/2152-7806.111302","volume":"4","author":"M Pekmezci","year":"2013","unstructured":"Pekmezci, M. & Perry, A. Neuropathology of brain metastases. Surg. Neurol. Int. 4, S245\u2013S255 (2013).","journal-title":"Surg. Neurol. Int."},{"key":"20144_CR27","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/nm.3729","volume":"20","author":"Z Zheng","year":"2014","unstructured":"Zheng, Z. et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat. Med. 20, 1479\u20131484 (2014).","journal-title":"Nat. Med."},{"key":"20144_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2014.09.019","volume":"26","author":"SC Bresler","year":"2014","unstructured":"Bresler, S. C. et al. ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell 26, 682\u2013694 (2014).","journal-title":"Cancer Cell"},{"key":"20144_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"20144_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1370-x","volume":"15","author":"HJ Schulten","year":"2017","unstructured":"Schulten, H. J. et al. Comprehensive molecular biomarker identification in breast cancer brain metastases. J. Transl. Med. 15, 269 (2017).","journal-title":"J. Transl. Med."},{"key":"20144_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","volume":"99","author":"ED Michelakis","year":"2008","unstructured":"Michelakis, E. D., Webster, L. & Mackey, J. R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br. J. Cancer 99, 989\u2013994 (2008).","journal-title":"Br. J. Cancer"},{"key":"20144_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110\u20131122 (2014).","journal-title":"Cell"},{"key":"20144_CR33","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/ijc.26031","volume":"128","author":"RR Langley","year":"2011","unstructured":"Langley, R. R. & Fidler, I. J. The seed and soil hypothesis revisited\u2013the role of tumor-stroma interactions in metastasis to different organs. Int. J. Cancer 128, 2527\u20132535 (2011).","journal-title":"Int. J. Cancer"},{"key":"20144_CR34","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ncb3011","volume":"16","author":"L Sevenich","year":"2014","unstructured":"Sevenich, L. et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat. Cell Biol. 16, 876\u2013888 (2014).","journal-title":"Nat. Cell Biol."},{"key":"20144_CR35","first-page":"188","volume":"50","author":"DF Wei","year":"2019","unstructured":"Wei, D. F., Tang, M. K., Liu, Y., Zhang, C. Y. & Qin, L. J. Effect of hypoxia inducible factor-1 alpha on brain metastasis from lung cancer and its mechanism. J. Sichuan University (Med Sciences Edition)\u00a050, 188\u2013192 (2019).","journal-title":"J. Sichuan University (Med Sciences Edition)"},{"key":"20144_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1158\/1541-7786.MCR-12-0629","volume":"11","author":"DM Gilkes","year":"2013","unstructured":"Gilkes, D. M. et al. Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis. Mol. Cancer Res. 11, 456\u2013466 (2013).","journal-title":"Mol. Cancer Res."},{"key":"20144_CR37","doi-asserted-by":"publisher","first-page":"E3234","DOI":"10.1073\/pnas.1410041111","volume":"111","author":"T Wang","year":"2014","unstructured":"Wang, T. et al. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc. Natl. Acad. Sci. USA 111, E3234\u2013E3242 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20144_CR38","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41388-018-0259-3","volume":"37","author":"A Chen","year":"2018","unstructured":"Chen, A. et al. Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene 37, 4214\u20134225 (2018).","journal-title":"Oncogene"},{"key":"20144_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/ncb3465","volume":"19","author":"G Fluegen","year":"2017","unstructured":"Fluegen, G. et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat. Cell Biol. 19, 120\u2013132 (2017).","journal-title":"Nat. Cell Biol."},{"key":"20144_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12412-1","volume":"10","author":"I Godet","year":"2019","unstructured":"Godet, I. et al. Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nat. Commun. 10, 4862 (2019).","journal-title":"Nat. Commun."},{"key":"20144_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0360-3016(94)90432-4","volume":"29","author":"R Rampling","year":"1994","unstructured":"Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A. & Workman, P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J. Radiat. Oncol. Biol. Phys. 29, 427\u2013431 (1994).","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"20144_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/ars.2007.1628","volume":"9","author":"P Vaupel","year":"2007","unstructured":"Vaupel, P., Hockel, M. & Mayer, A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid. Redox Signal 9, 1221\u20131235 (2007).","journal-title":"Antioxid. Redox Signal"},{"key":"20144_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/35035093","volume":"407","author":"T Burmester","year":"2000","unstructured":"Burmester, T., Weich, B., Reinhardt, S. & Hankeln, T. A vertebrate globin expressed in the brain. Nature 407, 520\u2013523 (2000).","journal-title":"Nature"},{"key":"20144_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3087","volume":"14","author":"LP Schwab","year":"2012","unstructured":"Schwab, L. P. et al. Hypoxia-inducible factor 1alpha promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res. 14, R6 (2012).","journal-title":"Breast Cancer Res."},{"key":"20144_CR45","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/onc.2011.365","volume":"31","author":"H Zhang","year":"2012","unstructured":"Zhang, H. et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31, 1757\u20131770 (2012).","journal-title":"Oncogene"},{"key":"20144_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2559.2005.02045.x","volume":"46","author":"R Bos","year":"2005","unstructured":"Bos, R. et al. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46, 31\u201336 (2005).","journal-title":"Histopathology"},{"key":"20144_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep21520","volume":"6","author":"H Mori","year":"2016","unstructured":"Mori, H. et al. Induction of WNT11 by hypoxia and hypoxia-inducible factor-1alpha regulates cell proliferation, migration and invasion. Sci. Rep. 6, 21520 (2016).","journal-title":"Sci. Rep."},{"key":"20144_CR48","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.molonc.2014.05.009","volume":"8","author":"J Seoane","year":"2014","unstructured":"Seoane, J. & Mattos-Arruda, L. De. Brain metastasis: new opportunities to tackle therapeutic resistance. Mol. Oncol. 8, 1120\u20131131 (2014).","journal-title":"Mol. Oncol."},{"key":"20144_CR49","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1158\/1078-0432.CCR-17-3351","volume":"24","author":"S Kabraji","year":"2018","unstructured":"Kabraji, S. et al. Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain? Clin. Cancer Res. 24, 1795\u20131804 (2018).","journal-title":"Clin. Cancer Res."},{"key":"20144_CR50","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jamaoncol.2016.0238","volume":"2","author":"MD Pegram","year":"2016","unstructured":"Pegram, M. D. Neratinib in ERBB2-positive brain metastases. JAMA Oncol. 2, 1541\u20131543 (2016).","journal-title":"JAMA Oncol."},{"key":"20144_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz, B., de la Puente, P., Azab, F. & Azab, A. K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl.) 3, 83\u201392 (2015).","journal-title":"Hypoxia"},{"key":"20144_CR52","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1078-0432.CCR-14-2075","volume":"21","author":"YS Lu","year":"2015","unstructured":"Lu, Y. S. et al. Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy. Clin. Cancer Res. 21, 1851\u20131858 (2015).","journal-title":"Clin. Cancer Res."},{"key":"20144_CR53","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1126\/science.aay0939","volume":"367","author":"RY Ebright","year":"2020","unstructured":"Ebright, R. Y. et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science 367, 1468\u20131473 (2020).","journal-title":"Science"},{"key":"20144_CR54","doi-asserted-by":"crossref","unstructured":"Baumann, B. C., Dorsey, J. F., Benci, J. L., Joh, D. Y. & Kao, G. D. Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme. J. Vis. Exp.\u00a067,\u00a04089\u00a0(2012).","DOI":"10.3791\/4089"},{"key":"20144_CR55","first-page":"95","volume":"3","author":"Z Dai","year":"2014","unstructured":"Dai, Z. et al. edgeR: a versatile tool for the analysis of shRNA-seq and CRISPR-Cas9 genetic screens. F1000Res 3, 95 (2014).","journal-title":"F1000Res"},{"key":"20144_CR56","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nprot.2014.044","volume":"9","author":"NM Karabacak","year":"2014","unstructured":"Karabacak, N. M. et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat. Protoc. 9, 694\u2013710 (2014).","journal-title":"Nat. Protoc."},{"key":"20144_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"91","author":"N Otsu","year":"1979","unstructured":"Otsu, N. A threshold selection method from gray-level histograms.IEEE Trans. Sys. Man Cyber. 91, 62\u201366 (1979).","journal-title":"IEEE Trans. Sys. Man Cyber."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20144-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T21:21:09Z","timestamp":1670275269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20144-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["20144"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20144-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.T.T., M.T., D.A.H., and S.M. are founders of and own equity in TellBio, Inc., which is involved with CTC therapeutics and diagnostic. At this time, there has been no funding received or license that has been given to TellBio, Inc. for this work. D.T.T. is also a founder and owns equity in ROME Therapeutics and PanTher Therapeutics, which is not related to this work. D.T.T. has received consulting fees from ROME Therapeutics, Foundation Medicine, Inc., NanoString Technologies, EMD Millipore Sigma, and Pfizer that are not related to this work. D.T.T. receives research support from ACD-Biotechne, PureTech Health LLC, Ribon Therapeutics, which was not used in this work. D.T.T.\u2019s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies. P.K.B. has received research support (to Massachusetts General Hospital) from Merck, Pfizer, Lilly, and BMS. P.K.B. has consulted for Genentech-Roche, ElevateBio, Lilly, and AngioChem. P.K.B. has received Speaker\u2019s Honoraria from Genentech-Roche and Merck. R.Y.E. has received consulting fees from Nextech Invest and nference Inc., which are not related to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6311"}}